![]() |
|||||||||||||
|
All | Since 2019 | |
Citation | 5450 | 3969 |
h-index | 23 | 20 |
i10-index | 134 | 84 |
CLINICAL PHARMACOLOGY OF ERYTHROMYCIN
Gian Maria Pacifici*
ABSTRACT
Erythromycin is a macrolide antibiotic and erythromycin usually is bacteriostatic but may be bactericidal in high concentrations against susceptible organisms. Erythromycin has good activity against streptococci, Streptococcus pneumoniae, methicillin-susceptible and methicillin-resistant Staphylococcus aureus, Enterococcus faecalis, and Enterococcus faecium but macrolide resistance among Streptococcus pneumoniae often coexist with penicillin resistance. Gram-positive bacilli are frequently sensitive to erythromycin, including Clostridium perfringens, Corynebacterium diphtheriae, and Listeria monocytogenes. Erythromycin has modest activity in-vitro against Haemophilus influenzae and Neisseria meningitis and has good activity against Neisseria gonorrhoea Borrelia species, Bordetella Keywords: Drug-interaction, efficacy-safely, erythromycin, pharmacokinetics, prophylaxis, tissue-penetration, toxicity, treatment, and trials. [Download Article] [Download Certifiate] |